详情页 - 广东省中医院知识库

资源类型：

文章类型：

作者：

Su Bin[1] * ; Yao Cheng[2] * ; Zhao Qing-Xia[3] * ; Cai Wei-Ping[4] * ; Wang Min[5] * ; Lu Hong-Zhou[6] * ; Mu Ting-Ting[1] * ; Chen Yuan-Yuan[3] ; Liu Li[6] ; Wang Hui[7] ; He Yun[7] ; Zheng Yu-Huang[8] ; Li Ling-Hua[4] ; Chen Jin-Feng[4] ; Yu Jian-Hua[9] ; Zhu Biao[10] ; Zhao Min[11] ; Sun Yong-Tao[12] ; Lun Wen-Hui[13] ; Zhang Yi-Hang[1] ; Wang Hu[1] ; Xia Wei[1] ; Sun Li-Jun[1] ; Dai Li-Li[1] ; Jiang Tai-Yi[1] ; Wang Mei-Xia[1] ; Zheng Qing-Shan[14] ; Peng Hai-Yan[15] ; Wang Yao[15] ; Hu Min[2] ; Liu Xia[2] ; Lu Rong-Jian[2] ; Hu Jian-Hua[2] ; Sun Cheng-Chen[2] ; Xing Hui[16] ; Shao Yi-Ming[16] ; Xie Dong[2] ; Zhang Tong[1] ; Zhang Fu-Jie[13] ; Wu Hao[1] ;

机构： [1]Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China. [2]Frontier Biotechnologies Inc., Nanjing, Jiangsu 211122, China. [3]Department of Infectious Diseases, Infectious Disease Hospital of Henan Province, Zhengzhou, Henan 450061, China. [4]Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510060, China. [5]Institute of HIV/AIDS, the First Hospital of Changsha, Changsha, Hunan 410005, China. [6]Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China. [7]Department of Infectious Diseases, National Clinical Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, Guangdong 518112, China. [8]Department of Infectious Diseases, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China. [9]Department of Infectious Diseases, Xixi Hospital of Hangzhou, Hangzhou, Zhejiang 310023, China. [10]State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang 310003, China. [11]National Clinical Research Center for Infectious Diseases, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China. [12]Department of Infectious Diseases, Tangdu Hospital, the Fourth Military Medical University, Xi'an Shaanxi 710038, China. [13]Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China. [14]Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. [15]Beijing Co-CRO Medical Development Co., Ltd., Beijing 100711, China. [16]State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China

出处：

DOI：

ISSN：

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2021]版：

大类 | 2 区医学

小类 | 2 区传染病学

最新[2025]版：

大类 | 2 区医学

小类 | 1 区传染病学

第一作者：

第一作者机构： [1]Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.

共同第一作者：

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

Long-acting HIV fusion inhibitor albuvirtide combined with ritonavir-boosted lopinavir for HIV-1-infected patients after failing the first-line antiretroviral therapy: 48-week randomized, controlled, phase 3 non-inferiority TALENT study.

文献详情